Gene Expression Changes of Brain Tissue in Human Temporal Lobe Epilepsy With Hippocampal Sclerosis
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- RNA sequencing data
研究概览
简要总结
Epilepsy is a common neurological disease, manifested in the sudden abnormal discharge of neurons leading to short-term brain dysfunction, has become the neurology after headache the second most common disease. In China, the prevalence of epilepsy is about 4.7-8.5 per 1,000, and more than 400,000 new cases of epilepsy are developed each year. Of these, 30% of patients were treated with ineffective medication, developing into a drug-incurable epilepsy that required surgery and other treatments. The most common type of epilepsy is temporal lobe epilepsy, while the common complication in temporal lobe epilepsy is hippocampal sclerosis, which often requires surgical removal. The incidence of inner temporal lobe epilepsy associated with hippocampal sclerosis is increasing, but its exact cause and specific pathogenesis are still unclear, so clarifying its pathogenesis will contribute to the understanding of temporal lobe epilepsy and the improvement of surgical procedures. This study is intended to get single-cell transcriptome as well as spatial transcriptome data of temporal lobe and hippocampus samples. By studying gene expression change associated with epilepsy and hippocampus sclerosis, we intended to find possible prognostic-related molecules and to deepen understanding of pathological changes in epilepsy at the molecular level.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients confirmed in our hospital as having temporal lobe epilepsy and intending surgery to remove temporal lobe and hippocampal tissue;
- •Volunteer to participate in this clinical trial, comply with the requirements of this clinical trial and sign an informed consent form.
排除标准
- •Chronic diseases of the central nervous system other than temporal lobe epilepsy;
- •Other patients that are not suitable for this clinical trial determined by the researchers;
研究组 & 干预措施
epilepsy with HS
干预措施: RNA sequencing (Other)
epilepsy without HS
干预措施: RNA sequencing (Other)
结局指标
主要结局
RNA sequencing data
时间窗: up to 24 weeks
Single-cell sequencing and spatial transcription sequencing data of samples.
次要结局
未报告次要终点
研究者
Junming Zhu
Chief Physician
Second Affiliated Hospital, School of Medicine, Zhejiang University
